Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > It takes money to advance oncology R&D

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Mar 08, 2023 10:27am

102 Views

Post# 35325714

RE:RE:RE:It takes money to advance oncology R&D

Take yer pick FGP,

Either they are spending the dough $$ to make GLP happen, which will lead to these other Phase 1s, probably small/cheap Canada only studies, or they have the $$ in the coffers to make it to Sept before looking for the next pp.

Bashers gotta bash, right?

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles